# MAP1LC3A

## Overview
The MAP1LC3A gene encodes the microtubule-associated protein 1 light chain 3 alpha (LC3A), a critical component of the autophagy pathway. LC3A is a ubiquitin-like protein that plays a pivotal role in the formation and function of autophagosomes, which are essential for the degradation and recycling of cellular components. This protein is part of the ATG8 family and is characterized by its ability to undergo lipidation, a post-translational modification that facilitates its association with autophagosome membranes (Kabeya2000LC3; Pan2019Structural). LC3A interacts with various proteins through its LC3-interacting region (LIR) motifs, contributing to its involvement in cellular processes such as mitophagy and vesicle trafficking (Strappazzon2014AMBRA1; Cheng2016Structural). The gene's expression and the protein's function are implicated in several diseases, including polycystic ovary syndrome and certain cancers, highlighting its significance in both normal cellular homeostasis and pathological conditions (Yang2024Identification; Lebovitz2015Crosscancer).

## Structure
The MAP1LC3A protein, also known as LC3A, is a member of the ATG8 family involved in autophagy. It has a primary structure consisting of 125 amino acids, with a molecular weight of 14,492.80 Da and an isoelectric point of 7.78 (Mirzaei2022Bioinformatics). The secondary structure of LC3A includes two N-terminal α-helices, which are important for protein-protein interactions, and a ubiquitin-like core structure (Pan2019Structural). This ubiquitin-like core is a conserved feature among ATG8 family proteins, despite differences in amino acid sequences that affect their specific functions (Pan2019Structural).

LC3A undergoes post-translational modifications, such as lipidation, which is crucial for its role in autophagosome formation. This process involves conjugation with phosphatidylethanolamine (PE), transforming LC3-I into LC3-II, which is associated with autophagosome membranes (Pan2019Structural). The protein also interacts with other proteins, such as FYCO1, through a specific LC3-interacting region (LIR), which involves hydrophobic and polar interactions, contributing to its role in autophagosome transport (Cheng2016Structural). The interaction with FYCO1 is mediated by a novel binding mode, highlighting the structural adaptability of LC3A in autophagic processes (Cheng2016Structural).

## Function
The MAP1LC3A gene encodes the microtubule-associated proteins 1A/1B light chain 3 A (LC3), which plays a crucial role in the autophagy process in human cells. Autophagy is a cellular mechanism responsible for degrading and recycling cellular components, thereby maintaining cellular homeostasis and responding to stress conditions. LC3 is involved in the formation of autophagosomes, which are vesicles that sequester damaged organelles and proteins for degradation (Kabeya2000LC3; Mirzaei2022Bioinformatics).

LC3 exists in two forms: LC3-I, which is cytosolic, and LC3-II, which is membrane-bound and specifically associated with autophagosome membranes. The conversion of LC3-I to LC3-II is a key step in autophagosome formation, and the amount of LC3-II correlates with the number of autophagosomes, making it a marker for autophagy (Kabeya2000LC3). LC3-II is localized on the surface of autophagosomes and is involved in the early stages of autophagosome biogenesis (Kabeya2000LC3).

The protein is active in various cellular components, including the cytoplasm, cytosol, and autophagosome membrane, and is involved in several biological processes such as cellular responses to nutrient levels and stress conditions (Mirzaei2022Bioinformatics).

## Clinical Significance
Alterations in the expression of the MAP1LC3A gene have been implicated in several diseases, particularly polycystic ovary syndrome (PCOS). In PCOS, MAP1LC3A is significantly overexpressed, and its expression is positively correlated with testosterone levels, suggesting a role in ovulation disorders associated with the condition (Yang2024Identification). The gene's expression is also linked to changes in the immune microenvironment in PCOS patients, indicating its potential as a biomarker for the disease (Yang2024Identification).

In the context of cancer, MAP1LC3A has been associated with various malignancies. In acute myeloid leukemia (LAML), increased expression of MAP1LC3A is observed in certain patient subgroups, potentially supporting the survival of blast cells with defective differentiation programs (Lebovitz2015Crosscancer). In uterine corpus endometrial carcinomas (UCEC), higher counts of MAP1LC3A-related structures are found in aggressive subtypes, suggesting a role in tumor progression (Lebovitz2015Crosscancer).

The gene is also involved in autophagy, a process crucial for cellular homeostasis. Alterations in MAP1LC3A expression or its interactions, such as with the autophagy adaptor FYCO1, may impact autophagic vesicle trafficking, potentially influencing disease processes (Cheng2016Structural).

## Interactions
MAP1LC3A, also known as LC3, is a key protein involved in autophagy and interacts with various proteins through its LC3-interacting region (LIR) motifs. It binds with AMBRA1, an upstream autophagy regulator, facilitating mitophagy independently of PARKIN and p62/SQSTM1. This interaction is crucial for mitochondrial clearance, highlighting AMBRA1's role in LC3-dependent mitophagy pathways (Strappazzon2014AMBRA1).

MAP1LC3A also interacts with FYCO1, an autophagy adaptor protein. The interaction is mediated by the LIR motif of FYCO1, which binds specifically to MAP1LC3A, playing a significant role in autophagic vesicle trafficking. This binding involves a unique mode characterized by strong hydrophobic and polar interactions (Cheng2016Structural).

Additionally, MAP1LC3A interacts with TBC domain-containing Rab GTPase-activating proteins (GAPs), such as TBC1D5. These interactions are mediated through LIR motifs and are implicated in regulating autophagy and endocytic pathways. TBC1D5's interaction with MAP1LC3A suggests a role in switching between vesicle-trafficking pathways, particularly during starvation-induced autophagy (Popovic2012Rab).


## References


[1. (Strappazzon2014AMBRA1) F Strappazzon, F Nazio, M Corrado, V Cianfanelli, A Romagnoli, G M Fimia, S Campello, R Nardacci, M Piacentini, M Campanella, and F Cecconi. Ambra1 is able to induce mitophagy via lc3 binding, regardless of parkin and p62/sqstm1. Cell Death &amp; Differentiation, 22(3):419–432, September 2014. URL: http://dx.doi.org/10.1038/cdd.2014.139, doi:10.1038/cdd.2014.139. This article has 267 citations.](https://doi.org/10.1038/cdd.2014.139)

[2. (Lebovitz2015Crosscancer) Chandra B Lebovitz, A Gordon Robertson, Rodrigo Goya, Steven J Jones, Ryan D Morin, Marco A Marra, and Sharon M Gorski. Cross-cancer profiling of molecular alterations within the human autophagy interaction network. Autophagy, 11(9):1668–1687, September 2015. URL: http://dx.doi.org/10.1080/15548627.2015.1067362, doi:10.1080/15548627.2015.1067362. This article has 107 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2015.1067362)

[3. (Popovic2012Rab) Doris Popovic, Masato Akutsu, Ivana Novak, J. Wade Harper, Christian Behrends, and Ivan Dikic. Rab gtpase-activating proteins in autophagy: regulation of endocytic and autophagy pathways by direct binding to human atg8 modifiers. Molecular and Cellular Biology, 32(9):1733–1744, May 2012. URL: http://dx.doi.org/10.1128/mcb.06717-11, doi:10.1128/mcb.06717-11. This article has 159 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.06717-11)

[4. (Kabeya2000LC3) Y. Kabeya. Lc3, a mammalian homologue of yeast apg8p, is localized in autophagosome membranes after processing. The EMBO Journal, 19(21):5720–5728, November 2000. URL: http://dx.doi.org/10.1093/emboj/19.21.5720, doi:10.1093/emboj/19.21.5720. This article has 5364 citations.](https://doi.org/10.1093/emboj/19.21.5720)

[5. (Pan2019Structural) Lifeng Pan, Jianping Liu, and Ying Li. Structural Basis of Autophagy Regulatory Proteins, pages 287–326. Springer Singapore, 2019. URL: http://dx.doi.org/10.1007/978-981-15-0602-4_15, doi:10.1007/978-981-15-0602-4_15. This article has 6 citations.](https://doi.org/10.1007/978-981-15-0602-4_15)

[6. (Yang2024Identification) Yizhen Yang, Xiaojing Chen, Xiuhua Liao, Wenwen Jiang, Yuan Zhou, Yan Sun, and Beihong Zheng. Identification of map1lc3a as a promising mitophagy-related gene in polycystic ovary syndrome. Scientific Reports, July 2024. URL: http://dx.doi.org/10.1038/s41598-024-67969-9, doi:10.1038/s41598-024-67969-9. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-67969-9)

[7. (Mirzaei2022Bioinformatics) Ali Mirzaei and Farzaneh Fazeli. Bioinformatics analysis of microtubule-associated protein-1 light chain 3 (map1lc3a) and (becn1) genes in autophagy. Cellular, Molecular and Biomedical Reports, 2(3):129–137, September 2022. URL: http://dx.doi.org/10.55705/cmbr.2022.345001.1046, doi:10.55705/cmbr.2022.345001.1046. This article has 2 citations.](https://doi.org/10.55705/cmbr.2022.345001.1046)

[8. (Cheng2016Structural) Xiaofang Cheng, Yingli Wang, Yukang Gong, Faxiang Li, Yujiao Guo, Shichen Hu, Jianping Liu, and Lifeng Pan. Structural basis of fyco1 and map1lc3a interaction reveals a novel binding mode for atg8-family proteins. Autophagy, 12(8):1330–1339, June 2016. URL: http://dx.doi.org/10.1080/15548627.2016.1185590, doi:10.1080/15548627.2016.1185590. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2016.1185590)